P J Snyder

Author PubWeight™ 110.10‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men. J Clin Endocrinol Metab 2000 2.68
2 Gonadotroph adenoma in a premenopausal woman secreting follicle-stimulating hormone and causing ovarian hyperstimulation. J Clin Endocrinol Metab 1995 2.20
3 Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men. J Clin Endocrinol Metab 2000 1.99
4 A factor analysis of the Klein sexual orientation grid in two disparate samples. Arch Sex Behav 1993 1.98
5 Increased serum prolactin after administration of synthetic thyrotropin releasing hormone (TRH) in man. J Clin Endocrinol Metab 1971 1.96
6 Response to thyrotropin releasing hormone (TRH) in normal man. J Clin Endocrinol Metab 1972 1.82
7 Digital topological analysis of in vivo magnetic resonance microimages of trabecular bone reveals structural implications of osteoporosis. J Bone Miner Res 2001 1.80
8 Inhibition of thyrotropin response to thyrotropin-releasing hormone by small quantities of thyroid hormones. J Clin Invest 1972 1.77
9 Hypothyroidism in workers exposed to polybrominated biphenyls. N Engl J Med 1980 1.73
10 Recognition of gonadotroph adenomas in women. N Engl J Med 1991 1.70
11 Intranasal trigeminal stimulation from odorous volatiles: psychometric responses from anosmic and normal humans. Physiol Behav 1978 1.69
12 Identification of two point mutations and a one base deletion in exon 19 of the dystrophin gene by heteroduplex formation. Hum Mol Genet 1993 1.67
13 Neuropsychiatric side effects related to treatment with felbamate. J Neuropsychiatry Clin Neurosci 1996 1.46
14 A cohort mortality study of two California refinery and petrochemical plants. J Occup Med 1993 1.45
15 Synthetic thyrotropin-releasing hormone. A potent stimulator of thyrotropin secretion in man. N Engl J Med 1971 1.40
16 The role of androgens in women. J Clin Endocrinol Metab 2001 1.40
17 Kallmann syndrome: MR evaluation of olfactory system. AJNR Am J Neuroradiol 1993 1.24
18 Cross-sectional study of osteopenia with quantitative MR imaging and bone densitometry. Radiology 2000 1.23
19 Thyrotropin response to thyrotropin releasing hormone in normal females over forty. J Clin Endocrinol Metab 1972 1.23
20 Absence of regional hemispheric volume asymmetries in first-episode schizophrenia. Am J Psychiatry 1994 1.23
21 Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B Study. J Clin Oncol 2001 1.20
22 Endocrine, cardiovascular, and psychological correlated of olfactory sensitivity changes during the human menstrual cycle. J Comp Physiol Psychol 1981 1.19
23 Withdrawal reaction from long-term, low-dosage administration of diazepam. A double-blind, placebo-controlled case study. Arch Gen Psychiatry 1980 1.18
24 A missense mutation in the dystrophin gene in a Duchenne muscular dystrophy patient. Nat Genet 1993 1.15
25 Spectrum of small mutations in the dystrophin coding region. Am J Hum Genet 1995 1.15
26 Prolactin response to thyrotropin releasing hormone in normal subjects. J Clin Endocrinol Metab 1973 1.10
27 Testicular function after orchiopexy for unilaterally undescended testis. N Engl J Med 1976 1.08
28 Octreotide treatment of acromegaly. A randomized, multicenter study. Ann Intern Med 1992 1.07
29 Gonadotroph cell adenomas of the pituitary. Endocr Rev 1985 1.04
30 Effects of transdermal testosterone gel on bone turnover markers and bone mineral density in hypogonadal men. Clin Endocrinol (Oxf) 2001 1.04
31 Treatment of male hypogonadism with testosterone enanthate. J Clin Endocrinol Metab 1980 1.03
32 Hypothalamic endocrinopathy in Hand-Schüller-Christian disease. Ann Intern Med 1978 1.02
33 Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N Engl J Med 1985 1.01
34 Safety and efficacy of long-term octreotide therapy of acromegaly: results of a multicenter trial in 103 patients--a clinical research center study. J Clin Endocrinol Metab 1995 1.00
35 Pentose cycle in isolated islets during glucose-stimulated insulin release. Am J Physiol 1970 1.00
36 Diagnostic value of thyrotrophin-releasing hormone in pituitary and hypothalamic diseases. Assessment of thyrotrophin and prolactin secretion in 100 patients. Ann Intern Med 1974 0.98
37 Low serum triiodothyronine in patients with anorexia nervosa. J Clin Endocrinol Metab 1975 0.98
38 Cystic ovarian metastasis from papillary thyroid carcinoma: a case report. Thyroid 2001 0.98
39 Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone. J Clin Invest 1973 0.97
40 Dystrophin expression in a Duchenne muscular dystrophy patient with a frame shift deletion. Neurology 1997 0.96
41 Is the haematopoietic effect of testosterone mediated by erythropoietin? The results of a clinical trial in older men. Andrology 2012 0.96
42 Mutant small heat shock protein B3 causes motor neuropathy: utility of a candidate gene approach. Neurology 2010 0.94
43 Use of L-glutamine in total parenteral nutrition. J Surg Res 1988 0.94
44 The influence of estrous cycle and intrastriatal estradiol on sensorimotor performance in the female rat. Pharmacol Biochem Behav 1987 0.93
45 Repetitive infusion of gonadotropin-releasing hormone distinguishes hypothalamic from pituitary hypogonadism. J Clin Endocrinol Metab 1979 0.92
46 Serum LH and FSH responses to the repetitive administration of gonadotropin-releasing hormone in patients with idiopathic hypogonadotropic hypogonadism. J Clin Endocrinol Metab 1975 0.92
47 A nodule-specific sequence encoding a methionine-rich polypeptide, nodulin-21. Plant Mol Biol 1990 0.92
48 Effect of glutamine-supplemented total parenteral nutrition on recovery of the small intestine after starvation atrophy. JPEN J Parenter Enteral Nutr 1993 0.90
49 Hybrids monosomal for human chromosome 5 reveal the presence of a spinal muscular atrophy (SMA) carrier with two SMN1 copies on one chromosome. Hum Genet 2001 0.90
50 Testosterone-induced inhibition of the LH and FSH responses to gonadotropin-releasing hormone occurs slowly. J Clin Endocrinol Metab 1977 0.89
51 Gonadotropin releasing hormone release from the rat hypothalamus: dependence on membrane depolarization and calcium influx. Endocrinology 1978 0.87
52 Gynecomastia and semen abnormalities induced by spironolactone in normal men. J Clin Endocrinol Metab 1977 0.87
53 Foreign Accent Syndrome following a catastrophic second injury: MRI correlates, linguistic and voice pattern analyses. Brain Cogn 2000 0.87
54 Determination of carrier status in Duchenne and Becker muscular dystrophies by quantitative polymerase chain reaction and allele-specific oligonucleotides. Clin Chem 1990 0.86
55 Evaluation of celiac disease biopsies for adenovirus 12 DNA using a multiplex polymerase chain reaction. Mod Pathol 1993 0.86
56 Heteroduplex analysis of the dystrophin gene: application to point mutation and carrier detection. Am J Med Genet 1994 0.86
57 Optimization of DNA extraction from formalin-fixed tissue and its clinical application in Duchenne muscular dystrophy. Am J Clin Pathol 1992 0.85
58 Secretion of uncombined subunits of luteinizing hormone by gonadotroph cell adenomas. J Clin Endocrinol Metab 1984 0.84
59 Intravenous glucose tolerance test and its modification by pregnancy. J Clin Endocrinol Metab 1970 0.84
60 Selective effect of insulin on glucose-U-C14 metabolism in rabbit liver slices. Am J Physiol 1965 0.83
61 Administration of gonadal steroids to the castrated male rat prevents a decrease in the release of gonadotropin-releasing hormone from the incubated hypothalamus. J Clin Invest 1979 0.83
62 Results of radiotherapy in the treatment of acromegaly: lack of ophthalmologic complications. Int J Radiat Oncol Biol Phys 1990 0.83
63 Serum LH and FSH responses to synthetic gonadotropin-releasing hormone in normal men. J Clin Endocrinol Metab 1975 0.83
64 New technique for quantitation of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonadotropin-releasing hormone antagonist. J Clin Endocrinol Metab 1993 0.83
65 Southern transfer protocol for confirmation of Huntington disease. Clin Chem 1996 0.83
66 Detection of cytomegalovirus in liver transplant biopsies. A comparison of light microscopy, immunohistochemistry, duplex PCR and nested PCR. Transplantation 1994 0.82
67 Gonadotroph adenomas in men produce biologically active follicle-stimulating hormone. J Clin Endocrinol Metab 1990 0.82
68 Clinical use of androgens. Annu Rev Med 1984 0.82
69 Treatment of primary hypogonadism in men by the transdermal administration of testosterone. J Clin Endocrinol Metab 1989 0.82
70 A molecular protocol for diagnosing myotonic dystrophy. Clin Chem 1995 0.81
71 Effects on the pituitary-thyroid axis and prolactin secretion of single and repetitive oral doses of thyrotropin-releasing hormone (TRH). J Clin Endocrinol Metab 1974 0.81
72 Exon 44 nonsense mutation in two-Duchenne muscular dystrophy brothers detected by heteroduplex analysis. Hum Mutat 1993 0.81
73 Hypersecretion of LH and FSH by a pituitary adenoma. J Clin Endocrinol Metab 1976 0.81
74 Methodological improvements in quantifying cognitive change in clinical trials: an example with single-dose administration of donepezil. J Nutr Health Aging 2009 0.81
75 Inhibition of thyrotropin releasing hormone-mediated secretion of thyrotropin by human growth hormone. J Clin Endocrinol Metab 1973 0.81
76 Mortality, morbidity, and haematological results from a cohort of long-term workers involved in 1,3-butadiene monomer production. Occup Environ Med 1994 0.80
77 Effect of glutamine-supplemented intravenous nutrition on survival after Escherichia coli-induced peritonitis. JPEN J Parenter Enteral Nutr 1993 0.80
78 Rapid DNA haplotyping using a multiplex heteroduplex approach: application to Duchenne muscular dystrophy carrier testing. Hum Mutat 1995 0.80
79 EHT0202 in Alzheimer's disease: a 3-month, randomized, placebo-controlled, double-blind study. Curr Alzheimer Res 2011 0.80
80 Long-term follow-up mortality study of petroleum refinery and chemical plant employees. Am J Ind Med 1996 0.80
81 Effect of intravenous flumazenil on oral midazolam pharmacokinetics and pharmacodynamics for use as a cytochrome P450 3A probe. Int J Clin Pharmacol Ther 2009 0.79
82 GABA levels within the medial preoptic area: effects of chronic administration of sodium valproic acid. Psychoneuroendocrinology 2000 0.79
83 Effect of enteral nutrition on human pancreatic secretions. JPEN J Parenter Enteral Nutr 1987 0.78
84 Thyrotropin-releasing hormone provokes abnormal follicle-stimulating hormone (FSH) and luteinizing hormone responses in men who have pituitary adenomas and FSH hypersecretion. J Clin Endocrinol Metab 1980 0.78
85 Repetitive administration of thyrotropin-releasing hormone results in small elevations of serum thyroid hormones and in marked inhibition of thyrotropin response. J Clin Invest 1973 0.78
86 Germline mosaicism at the fragile X locus. Am J Med Genet 1995 0.78
87 Fewer sperm in the summer--it's not the heat, it's... N Engl J Med 1990 0.78
88 Transverse myelitis. Comparison with spinal cord presentations of multiple sclerosis. Neurology 1998 0.78
89 Hypopituitarism following radiation therapy of pituitary adenomas. Am J Med 1986 0.78
90 Variability of hormonal responses to a series of neuroendocrine challenges in depressed patients. Am J Psychiatry 1982 0.78
91 Nonsense mutations in a Becker muscular dystrophy and an intermediate patient. Hum Mutat 1996 0.78
92 A HindIII/BglII dystrophin gene polymorphism in the African-American population. Hum Genet 1992 0.78
93 Multiple hormonal responses to protirelin (TRH) in depressed patients. Arch Gen Psychiatry 1983 0.77
94 Abnormal secretion of glycoprotein alpha-subunit and follicle-stimulating hormone (FSH) beta-subunit in men with pituitary adenomas and FSH hypersecretion. J Clin Endocrinol Metab 1980 0.77
95 Identification of gonadotroph adenomas in men with clinically nonfunctioning adenomas by the luteinizing hormone beta subunit response to thyrotropin-releasing hormone. J Clin Endocrinol Metab 1993 0.77
96 The effect of acute increase in urge to void on cognitive function in healthy adults. Neurourol Urodyn 2011 0.77
97 Secretion of chorionic gonadotropin by cultured human pituitary cells. J Clin Endocrinol Metab 1990 0.77
98 Transfection of human lactotroph adenoma cells with an adenovirus vector expressing tyrosine hydroxylase decreases prolactin release. J Clin Endocrinol Metab 1996 0.77
99 Gonadal function in fifty men with untreated pituitary adenomas. J Clin Endocrinol Metab 1979 0.76
100 The prolactin response to thyrotropin-releasing hormone does not distinguish teenaged males with hypogonadotropic hypogonadism from those with constitutional delay of growth and development. J Clin Endocrinol Metab 1985 0.76
101 Identification of a missense mutation, single base deletion and a polymorphism in the dystrophin exon 16. Hum Mol Genet 1994 0.76
102 Magnetic resonance imaging of pituitary lesions using 1.0 to 1.5 T field strength. Radiology 1984 0.76
103 Decreased follistatin gene expression in gonadotroph adenomas. J Clin Endocrinol Metab 1996 0.76
104 Testosterone pharmacokinetics after application of an investigational transdermal system in hypogonadal men. J Clin Pharmacol 1997 0.76
105 Vertebral deformities and fractures are associated with MRI and pQCT measures obtained at the distal tibia and radius of postmenopausal women. Osteoporos Int 2013 0.76
106 Serum inhibin concentrations before and during gonadotropin treatment in men with hypogonadotropic hypogonadism: physiological and clinical implications. J Clin Endocrinol Metab 1990 0.76
107 Effects of enteral feeding products on survival from Escherichia coli peritonitis. J Trauma 1994 0.75
108 Epilepsy as a "natural laboratory" for the study of human memory. Brain Cogn 1997 0.75
109 Expression of activin/inhibin subunit messenger ribonucleic acids by gonadotroph adenomas. J Clin Endocrinol Metab 1994 0.75
110 A novel splice site mutation in a Becker muscular dystrophy patient. J Med Genet 1996 0.75
111 Case of the month: germline mosaicism in carriers of Duchenne muscular dystrophy. Muscle Nerve 1992 0.75
112 Clinical and research contributions of the intracarotid amobarbital procedure to neuropsychology. Brain Cogn 1997 0.75
113 The computerization of industrial hygiene records. Am Ind Hyg Assoc J 1979 0.75
114 Similar isoelectric profiles of FSH from gonadotroph cell adenomas and non-adenomatous pituitaries. Acta Endocrinol (Copenh) 1986 0.75
115 Karhunen-Loève treatment to remove noise and facilitate data analysis in sensing, spectroscopy and other applications. Analyst 2014 0.75
116 Gonadotropin-releasing hormone-dependent chorionic gonadotropin secretion in a menopausal woman. J Clin Endocrinol Metab 1994 0.75
117 Supranormal FSH response to gonadotrophin-releasing hormone in oligospermic men with a normal basal serum FSH concentration. Clin Endocrinol (Oxf) 1977 0.75
118 Endocrine evaluation of the infertile male. Urol Clin North Am 1978 0.75
119 Thyrotropin and thyroidal responses to consecutive doses of thyrotropin-releasing hormone. J Clin Endocrinol Metab 1973 0.75
120 Transdermal delivery of testosterone. J Clin Endocrinol Metab 1987 0.75
121 Subjective mood state and perception of emotion in chimeric faces. Cortex 1992 0.75
122 Inhibition of follicle-stimulating hormone secretion from gonadotroph adenomas by repetitive administration of a gonadotropin-releasing hormone antagonist. J Clin Endocrinol Metab 1990 0.75
123 Bromocriptine treatment of prolactin-secreting pituitary adenomas may restore pituitary function. Ann Intern Med 1984 0.75
124 Gonadotrophin-secreting pituitary adenomas masquerading as primary ovarian failure. Clin Endocrinol (Oxf) 1986 0.75
125 Generalizability of aphasiology studies: nontraditional populations examined. Brain Lang 2000 0.75
126 Visual function in prolactinoma patients treated with bromocriptine. Ophthalmology 1985 0.75
127 Cerebral anesthesia for localization of speech: the contribution of W. James Gardner. Brain Lang 1997 0.75
128 Isolated straight sinus thrombosis: clinical and neuroradiologic correlates. J Neuroimaging 1998 0.75
129 Diurnal variation of growth hormone secretion following thyrotropin-releasing hormone infusion in normal men. Psychosom Med 1984 0.75
130 Sodium valproate alters GnRH-GABA interactions during development in seizure-prone mice. Brain Res 2000 0.75
131 Detection of an exon 53 polymorphism in the dystrophin gene. Hum Genet 1993 0.75
132 Comparison of hormonal secretory behavior of gonadotroph cell adenomas in vivo and in culture. J Clin Endocrinol Metab 1985 0.75
133 Cerebral hemispheric control of speech during the intracarotid sodium amytal procedure: An acoustic exploration. Brain Lang 1997 0.75
134 Dieldrin and endrin concentrations in a Louisiana estuary. Pestic Monit J 1971 0.75
135 Follicle-stimulating hormone-secreting pituitary adenomas: correlation of reduction of adenoma size with reduction of hormonal hypersecretion after transsphenoidal surgery. J Clin Endocrinol Metab 1983 0.75